Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease
Immunoglobulin A (IgA) is generally considered as a non-inflammatory regulator of mucosal immunity, and its importance in diversifying the gut microbiota is increasingly appreciated. IgA autoantibodies have been found in several autoimmune or chronic inflammatory diseases, but their role in pathophy...
Main Authors: | Amelie Bos, Esil Aleyd, Lydia P. E. van der Steen, P. J. Winter, Niels Heemskerk, Stephan M. Pouw, Louis Boon, Rene J. P. Musters, Jantine E. Bakema, Cassian Sitaru, Michel Cogné, Marjolein van Egmond |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.732977/full |
Similar Items
-
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
by: Myrthe A. M. van Delft, et al.
Published: (2023-04-01) -
IgA and FcαRI: Pathological Roles and Therapeutic Opportunities
by: Annelot Breedveld, et al.
Published: (2019-03-01) -
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
by: Amélie V. Bos, et al.
Published: (2022-09-01) -
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity
by: van Gool MMJ, et al.
Published: (2021-01-01) -
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
by: Geert van Tetering, et al.
Published: (2020-12-01)